Hemodynamic Response and Motor Functions Following Transcranial Direct Current Stimulation in Acute Stroke

NCT ID: NCT04051658

Last Updated: 2022-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-06

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to evaluate the possible effect of using dual-tDCS applied before conventional physical therapy on motor functions and hemodynamic response

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is generally accepted that transcranial direct current stimulation (tDCS) can induce change in cortical excitability and thus modulate brain plasticity in the human brain. tDCS has been used in neurorehabilitation to benefit ischemic stroke patients at different stages of stroke especially during acute, subacute, and chronic phase with positive and safety reports. After a unilateral stroke, the excitability of the affected hemisphere is decreased, an increase in the excitability of the unaffected hemisphere and an abnormally high interhemispheric inhibition (IHI) drive from the intact to lesioned hemisphere have been reported.

These neuronal reorganizations and plasticity begin in the very early stages after stroke. Prevent the abnormal IHI and thus increase the excitability of the affected hemisphere in the early phase would be beneficial for stroke rehabilitation.

Based on the polarity-specific effects, anodal tDCS increases cortical excitability and cathodal tDCS decreases cortical excitability. tDCS can be applied in two distinct montages: monocephalic and bi-hemispheric/dual-tDCS (applying two electrodes over both cerebral hemispheres at the same time). To induce post-stroke motor recovery, two different monocephalic montages are typically used: i) to restore excitability in the ipsilesional hemisphere: anode over the ipsilesional hemisphere and the cathode as the reference electrode placed over the contra-orbital area ii) to down-regulate excitability of the contralesional hemisphere and rebalance IHI: cathode over the contralesional hemisphere and the anode as the reference electrode. Dual-tDCS can be also applied, permitting simultaneous coupling of excitatory and inhibitory effects on both cortices. In the acute phase, there is few evidence regarding the effect of tDCS on upper or lower limbs motor functions. However no evidence for tDCS combined with training in the acute phase. Some previous studies reported a positive effect on upper or lower limbs performance of tDCS with physical therapy in subacute to chronic stroke. The immediate and long-term effectiveness of each tDCS montage (monocephalic and bi-hemispheric/dual-tDCS) without physical rehabilitation in acute stroke also has been reported. However, there is still unclear evidence regarding the best tDCS montage with conventional physical therapy for stroke recovery, especially for the early phase The mechanism underlying cortical excitability changes after tDCS is still elusive. However, one possible mechanism indicating a change in cortical activity is the subsequent variation in hemodynamic response. Since different montages of tDCS can induce different responses on brain excitability. Different methods have been developed for cerebral hemodynamic evaluations i.e. cerebral blood flow velocity (CBFV). Transcranial color-coded duplex ultrasonography (TCCD) has been used to measure CBFV through the major intracranial vessels through relatively thin bone windows. It is a non-invasive, relatively inexpensive, safe, and portable allowing bedside monitoring of CBFV that is convenient in the intensive care setting.

Five consecutive days for tDCS over the M1 appeared to be safe in acute stroke patient and tDCS over the M1 have been reported to improve motor functions and balance performance. Clinical outcomes that have been using in the clinical setting such as Fugl-Meyer Assessment for motor functions, strength assessed by hand-held dynamometer, Time up and go for dynamic balance and mobility, Five times sit to stand the test for dynamic balance and muscle strength will be used as a secondary motor outcome.

The aim of the present study is to investigate hemodynamic response and motor performance following difference montages of 5 tDCS sessions over the primary motor cortex (M1) applied before conventional physical therapy, at immediate after of 5-sessions and then follow up at 1 month.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

a four-arm parallel assignment involves four groups of participants which consists of anodal-, cathodal-, dual- and sham tDCS.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anodal-tDCS & PT

Anodal transcranial direct current stimulation (tDCS) will be applied for 20 mins before conventional physical therapy (about 1 hour). Anodal on the motor area (M1) of the affected hemisphere, Cathodal on the contralateral supraorbital area. The current intensity is fixed at 1.5 mA and the current will flow continuously. The physical therapist will give an intervention program base on the same basic conventional physical therapy treatment. The scope of intervention is administered to improve motor functions and cerebral hemodynamic.

Group Type EXPERIMENTAL

Transcranial direct current stimulation

Intervention Type DEVICE

tDCS will be applied in 1.5 mA, 20 mins before conventional physical therapy for 5 days. All experiments will be performed in random order for each subject.

Cathodal-tDCS & PT

Cathodal transcranial direct current stimulation (tDCS) will be applied for 20 mins before conventional physical therapy (about 1 hour). Anodal on the supraorbital area of the affected hemisphere, Cathodal on the primary motor area (M1) of the unaffected hemisphere. The current intensity is fixed at 1.5 mA and the current will flow continuously. The physical therapist will give an intervention program base on the same basic conventional physical therapy treatment. The scope of intervention is administered to improve motor functions and cerebral hemodynamic.

Group Type EXPERIMENTAL

Transcranial direct current stimulation

Intervention Type DEVICE

tDCS will be applied in 1.5 mA, 20 mins before conventional physical therapy for 5 days. All experiments will be performed in random order for each subject.

Dual-tDCS & PT

Dual transcranial direct current stimulation (tDCS) will be applied over C3-C4 or the motor area (M1) for 20 mins before conventional physical therapy (about 1 hour). Anodal on the affected hemisphere, Cathodal on the unaffected hemisphere. The current intensity is fixed at 1.5 mA and the current will flow continuously. The physical therapist will give an intervention program base on the same basic conventional physical therapy treatment. The scope of intervention is administered to improve motor functions and cerebral hemodynamic.

Group Type EXPERIMENTAL

Transcranial direct current stimulation

Intervention Type DEVICE

tDCS will be applied in 1.5 mA, 20 mins before conventional physical therapy for 5 days. All experiments will be performed in random order for each subject.

Sham-tDCS & PT

Dual transcranial direct current stimulation (tDCS) in sham mode will be applied over C3-C4 or the motor area (M1) for 20 mins before conventional physical therapy (about 1 hour). Anodal on the affected hemisphere, Cathodal on the unaffected hemisphere. The physical therapist will give an intervention program base on the same basic conventional physical therapy treatment. The scope of intervention is administered to improve motor functions and cerebral hemodynamic .

Group Type SHAM_COMPARATOR

Transcranial direct current stimulation

Intervention Type DEVICE

tDCS will be applied in 1.5 mA, 20 mins before conventional physical therapy for 5 days. All experiments will be performed in random order for each subject.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial direct current stimulation

tDCS will be applied in 1.5 mA, 20 mins before conventional physical therapy for 5 days. All experiments will be performed in random order for each subject.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Between 18 and 75 years of age
2. First ever-acute ischemic unilateral stroke in the anterior circulation (ACA or MCA territory), MRI/CT scan result is thus required.
3. Stroke onset from 2-10 days
4. Good level of consciousness (alert)
5. Free of any neurological antecedent, unstable condition that may increase the risk of stimulation such as epilepsy; although tDCS is believed to induce less or no risk of seizure and epileptic seizure have never been reported in tDCS study even in a study with active epilepsy (19).
6. No significant carotid artery occlusive disease (\< 50% internal carotid artery stenosis) as assessed by carotid duplex ultrasonography
7. Modified Ranking Scale ≤ 4

Exclusion Criteria

1. Recurrent stroke
2. Having score more than 20 points on the National Institute of Health Stroke Scale
3. Be unable to understand the instruction.
4. Presence of intracranial metal implantation, cochlear implant, or cardiac pacemaker.
5. Having as excessive pain in any joint of the lower limb (numerical pain rating score \> 7)
6. Open wound or wound infraction on scalp
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Research Council of Thailand

OTHER_GOV

Sponsor Role collaborator

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wanalee Klomjai, Ph.D

Role: STUDY_DIRECTOR

Mahidol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy, Mahidol University

Salaya, Nakonpathom, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MU-CIRB 2018/238.0712

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tDCS and Physical Therapy in Stroke
NCT00542256 COMPLETED NA
TDCS in Acute Stroke
NCT01701713 UNKNOWN NA